670 results match your criteria: "Swiss Institute of Allergy and Asthma Research SIAF[Affiliation]"

An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production.

Vet Immunol Immunopathol

January 2022

Division of Neurological Sciences, Vetsuisse Faculty, University of Bern, Länggassstrasse 124, CH-3001 Bern, Switzerland.

Allergen-specific immunotherapy (AIT) constitutes the only curative approach for allergy treatment. There is need for improvement of AIT in veterinary medicine, such as in horses suffering from insect bite hypersensitivity, an IgE-mediated dermatitis to Culicoides. Dendritic cell (DC)-targeting represents an efficient method to increase antigen immunogenicity.

View Article and Find Full Text PDF

The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19.

Int Immunol

March 2022

Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Herman-Burchard Strasse, Davos, Switzerland.

The coronavirus disease 2019 (COVID-19) pandemic causes an overwhelming number of hospitalization and deaths with a significant socioeconomic impact. The vast majority of studies indicate that asthma and allergic diseases do not represent a risk factor for COVID-19 susceptibility nor cause a more severe course of disease. This raises the opportunity to investigate the underlying mechanisms of the interaction between an allergic background and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a common and complex skin condition that varies greatly among patients, highlighting the need for personalized medical approaches.
  • Researchers conducted a study on 367 patients to explore factors linked to the severity of AD, using specific measurements and machine learning techniques.
  • Findings revealed that certain characteristics, like atopic stigmata and high levels of immunoglobulin E, increased the likelihood of severe AD, while being female or in specific age groups reduced that risk.
View Article and Find Full Text PDF

drives the resolution of allergic asthma.

iScience

October 2021

Department of Molecular Pneumology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Universitätsklinikum Erlangen, Erlangen, Germany.

RANTES is implicated in allergic asthma and in T cell-dependent clearance of infection. RANTES receptor family comprises CCR1, CCR3, and CCR5, which are G-protein-coupled receptors consisting of seven transmembrane helices. Infections with respiratory viruses like Rhinovirus cause induction of RANTES production by epithelial cells.

View Article and Find Full Text PDF

IL-33 receptor expression on myeloid and plasmacytoid dendritic cells after allergen challenge in patients with allergic rhinitis.

Int Immunopharmacol

December 2021

Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Electronic address:

The diversity of immune responses in allergic diseases is critically mediated by dendritic cells (DCs), including myeloid and plasmacytoid DCs. Allergen inhalation increased the release of IL-33 from patients with allergic rhinitis (AR), which affecting the downstream cells by binding to its receptor (ST2). However, the effects of inhaled allergens on the expression of ST2 by DCs and IL-33 on the function of mDCs are unknown.

View Article and Find Full Text PDF

Engineered IL-10: A matter of affinity.

Allergy

March 2022

Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.

Pleiotropic roles of IL-10. Immune cells including regulatory T cells and B cells, ILCregs, macrophages, and DCs produce IL-10, which exerts both anti-inflammatory and pro-inflammatory effects. In an anti-inflammatory state, IL-10 suppresses inflammatory signals from several immune cells.

View Article and Find Full Text PDF

It remains uncertain as to whether nutrient supplementation for the general population considered healthy could be useful in the prevention of RTIs, such as COVID-19. In this systematic review and meta-analysis, the evidence was evaluated for primary prevention of any viral respiratory tract infection (RTI) such as SARS-CoV-2, through supplementation of nutrients with a recognized role in immune function: multiple micronutrients, vitamin A, folic acid, vitamin B12, C, D, E, beta-carotene, zinc, iron and long-chain polyunsaturated fatty acids. The search produced 15,163 records of which 93 papers (based on 115 studies) met the inclusion criteria, resulting in 199,055 subjects (191,636 children and 7,419 adults) from 37 countries.

View Article and Find Full Text PDF
Article Synopsis
  • Since the emergence of COVID-19 in late 2019, there have been nearly 198 million confirmed cases globally, prompting research into the virus SARS-CoV-2 and its effects, particularly on individuals with allergies and asthma.
  • This review evaluates the impact of COVID-19 on patients with asthma and other allergic conditions, suggesting that allergy mechanisms might offer some protective benefits against severe COVID-19 outcomes, though further research is required.
  • It highlights important advancements in managing allergic diseases during the pandemic, along with recommendations from the European Academy of Allergy & Clinical Immunology on allergy clinic operations and the potential allergic reactions from COVID-19 vaccinations.*
View Article and Find Full Text PDF
Article Synopsis
  • Tregs are special immune cells that help keep our bodies balanced and fight off diseases, and cannabinoids (like those found in marijuana) could help make these cells work better.
  • Dendritic cells (DCs) in our immune system have special receptors for cannabinoids, but how these cannabinoids affect DCs is still not fully understood.
  • This study shows that cannabinoids can help create a kind of DCs that promote Tregs, which could lead to new treatments for different diseases where the immune system goes a bit out of control.
View Article and Find Full Text PDF

Non-immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol.

Ann Allergy Asthma Immunol

December 2021

Sean N. Parker Center for Allergy and Asthma Research, Stanford, California; Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University, Stanford, California.

View Article and Find Full Text PDF

Background: The impact of physical activity on immune response is a hot topic in exercise immunology, but studies involving asthmatic children are scarce. Our aims were to examine whether there were any differences in the level of physical activity and daily TV attendance, to assess its role on asthma control and immune responses to various immune stimulants.

Methods: Weekly physical activity and daily television attendance were obtained from questionnaires at inclusion of the PreDicta study.

View Article and Find Full Text PDF

Advances and highlights in biomarkers of allergic diseases.

Allergy

December 2021

Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.

Article Synopsis
  • There's been a rise in allergic diseases globally, driven by a type 2 immune response involving various immune cells, leading to significant medical and economic impacts.
  • Biomarkers play a crucial role in precision medicine by aiding in disease classification, diagnosis, therapy targeting, and treatment evaluation, with advancements in omics technologies enhancing their identification.
  • Recent research has focused on potential biomarkers for allergic diseases like asthma and atopic dermatitis, including sputum eosinophils and serum periostin, while also considering the implications of COVID-19 on managing these conditions.
View Article and Find Full Text PDF

The "epithelial barrier hypothesis" proposes that the exposure to various epithelial barrier-damaging agents linked to industrialization and urbanization underlies the increase in allergic diseases. The epithelial barrier constitutes the first line of physical, chemical, and immunological defense against environmental factors. Recent reports have shown that industrial products disrupt the epithelial barriers.

View Article and Find Full Text PDF

Background: Platelets are thought to be involved in the pathophysiology of asthma, presumably through direct adhesion to inflammatory cells, including group 2 innate lymphoid cells (ILC2s). Here, we tried to elucidate the effects of platelet adhesion to ILC2s in vitro and in vivo, as well as the mechanisms involved.

Methods: Alternaria-induced ILC2-dependent airway inflammation models using wild-type and c-mpl mice were evaluated.

View Article and Find Full Text PDF

Asthma is a complex and heterogeneous inflammatory airway disease primarily characterized by airway obstruction, which affects up to 15% of the population in Westernized countries with an increasing prevalence. Descriptive laboratory and clinical studies reveal that allergic asthma is due to an immunological inflammatory response and is significantly influenced by an individual's genetic background and environmental factors. Due to the limitations associated with human experiments and tissue isolation, direct mouse models of asthma provide important insights into the disease pathogenesis and in the discovery of novel therapeutics.

View Article and Find Full Text PDF

The Importance of Metabolism for Immune Homeostasis in Allergic Diseases.

Front Immunol

October 2021

Departamento de Ciencias Medicas Basicas, Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla Del Monte, Madrid, Spain.

There is increasing evidence that the metabolic status of T cells and macrophages is associated with severe phenotypes of chronic inflammation, including allergic inflammation. Metabolic changes in immune cells have a crucial role in their inflammatory or regulatory responses. This notion is reinforced by metabolic diseases influencing global energy metabolism, such as diabetes or obesity, which are known risk factors of severity in inflammatory conditions, due to the metabolic-associated inflammation present in these patients.

View Article and Find Full Text PDF
Article Synopsis
  • Last year saw major advancements in asthma management despite pandemic challenges, highlighting important discoveries in asthma mechanisms involving resident cells, epigenetics, and the innate immune system.
  • Precision immunology techniques, enhanced by artificial intelligence, played a key role in these advancements and aided in revising existing asthma treatment guidelines.
  • The review aims to summarize recent studies and clinical trials to give clinicians and researchers a clear update on the latest developments in asthma research from a practical viewpoint.
View Article and Find Full Text PDF

Microbiota composition and associated metabolic activities are essential for the education and development of a healthy immune system. Microbial dysbiosis, caused by risk factors such as diet, birth mode, or early infant antimicrobial therapy, is associated with the inception of allergic diseases. In turn, allergic diseases increase the risk for irrational use of antimicrobial therapy.

View Article and Find Full Text PDF

Cellular and molecular mechanisms of allergic asthma.

Mol Aspects Med

June 2022

Swiss Institute of Allergy and Asthma Research (SIAF), Hermann-Burchard Strasse 9, CH7265, Davos Wolfgand, Switzerland; Christine Kühne - Center for Allergy Research and Education, Davos, Switzerland.

Asthma is a chronic disease of the airways, which affects more than 350 million people worldwide. It is the most common chronic disease in children, affecting at least 30 million children and young adults in Europe. Asthma is a complex, partially heritable disease with a marked heterogeneity.

View Article and Find Full Text PDF